483
Organogenesis, Inc.Organogenesis, Inc. – FDA 483, Jun 8, 2018
Record Details
An FDA inspection of Organogenesis, Inc. in Canton, MA, a medical device manufacturer, revealed a significant issue regarding the establishment of requirements for suppliers and contractors. Specifically, the firm failed to adequately define the tests conducted by its contract laboratory for received tissues, leading to inconsistencies in documentation. This indicates a moderate severity issue related to quality control and supplier management.
View Company Profile
ID · ce2270e3-62b8-458d-9672-6a5afec21ad9
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.